Complications of multiple myeloma

被引：51

作者：

Blade, Joan ^{[1
]}

Rosinol, Laura ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Inst Hematol & Oncol, Postgrad Sch Hematol Farreras Valenti, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2007年 / 21卷 / 06期

关键词：

D O I：

10.1016/j.hoc.2007.08.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multiple myeloma, also known as myeloma or plasma cell myeloma, is a progressive hematologic disease. Complications of multiple myeloma include renal insufficiency, hematologic complications (anemia, bone marrow failure, bleeding disorders), infections, bone complications (pathologic fractures, spinal cord compression, hyercalcemia), and neurologic complications (spinal cord and nerve root compression, intracranial plasmacytomas, leptomeningeal involvement, among others). This article reviews these various complications connected to multiple myeloma, examining their various causes and possible treatment.

引用

页码：1231 / +

页数：17

共 73 条

[1]

ALEXANIAN R, 1990, ARCH INTERN MED, V150, P1693

[2]

[Anonymous], EUR J HAEMATOL, DOI DOI 10.1034/J.1600-0609.2000.90218.X

[3] Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].

Badros, A ;

Weikel, D ;

Salama, A ;

Goloubeva, O ;

Schneider, A ;

Rapoport, A ;

Fenton, R ;

Gahres, N ;

Sausville, E ;

Ord, R ;

Meiller, T .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952

[4] Results of autologous stem cell transplant in multiple myeloma patients with renal failure [J].

Badros, A ;

Barlogie, B ;

Siegel, E ;

Roberts, J ;

Langmaid, C ;

Zangari, M ;

Desikan, R ;

Shaver, MJ ;

Fassas, A ;

McConnell, S ;

Muwalla, F ;

Barri, Y ;

Anaissie, E ;

Munshi, N ;

Tricot, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) :822-829

[5] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].

Bamias, A ;

Kastritis, E ;

Bamia, C ;

Moulopoulos, LA ;

Melakopoulos, L ;

Bozas, G ;

Koutsoukou, V ;

Gika, D ;

Anagnostopoulos, A ;

Papadimitriou, C ;

Terpos, E ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587

[6] American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma [J].

Berenson, JR ;

Hillner, BE ;

Kyle, RA ;

Anderson, K ;

Lipton, A ;

Yee, GC ;

Biermann, JS .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3719-3736

[7] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, MJ ;

Blacklock, HA ;

Bell, R ;

Simeone, J ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493

[8] CHEMOTHERAPY OF PLASMA-CELL MYELOMA AND THE INCIDENCE OF ACUTE-LEUKEMIA [J].

BERGSAGEL, DE ;

BAILEY, AJ ;

LANGLEY, GR ;

MACDONALD, RN ;

WHITE, DF ;

MILLER, AB .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (14) :743-748

[9]

BERGSAGEL DE, 1982, CLIN HAEMATOL, V11, P221

[10]

BERGUIN Y, 1992, BRIT J HAEMATOL, V82, P648

← 1 2 3 4 5 6 7 8 →